1. Home
  2. LADR vs EVO Comparison

LADR vs EVO Comparison

Compare LADR & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ladder Capital Corp

LADR

Ladder Capital Corp

N/A

Current Price

$10.06

Market Cap

1.3B

Sector

Real Estate

ML Signal

N/A

Logo Evotec SE

EVO

Evotec SE

N/A

Current Price

$2.43

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LADR
EVO
Founded
2008
1993
Country
United States
Germany
Employees
N/A
4766
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
LADR
EVO
Price
$10.06
$2.43
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$13.00
$7.00
AVG Volume (30 Days)
529.6K
127.2K
Earning Date
05-07-2026
01-01-0001
Dividend Yield
9.05%
N/A
EPS Growth
N/A
N/A
EPS
0.51
N/A
Revenue
N/A
N/A
Revenue This Year
$33.36
N/A
Revenue Next Year
$17.60
$7.13
P/E Ratio
$19.92
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.68
$2.48
52 Week High
$11.92
$4.80

Technical Indicators

Market Signals
Indicator
LADR
EVO
Relative Strength Index (RSI) 33.27 23.63
Support Level N/A N/A
Resistance Level $11.37 $3.78
Average True Range (ATR) 0.18 0.10
MACD -0.01 -0.10
Stochastic Oscillator 21.64 0.00

Price Performance

Historical Comparison
LADR
EVO

About LADR Ladder Capital Corp

Ladder Capital Corp is an internally-managed real estate investment trust that is in commercial real estate finance. The company originates and invests in a diverse portfolio of commercial real estate and real estate-related assets, focusing on senior secured assets. The company's investment activities include: (i) Primary business of originating senior first mortgage fixed and floating rate loans collateralized by commercial real estate with flexible loan structures; (ii) owning and operating commercial real estate, including net leased commercial properties; and (iii) investing in investment-grade securities secured by first mortgage loans on commercial real estate. The company has three reportable segments: Loans, which derive maximum revenue; Securities; and Real Estate.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: